Cargando…

Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19

Antecedent use of renin-angiotensin system inhibitors (RASi) prevents clinical deterioration and protects against cardiovascular/thrombotic complications of COVID-19, for indicated patients. Uncertainty exists regarding treatment continuation throughout infection and doing so with concomitant medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palazzuoli, Alberto, Tecson, Kristen M., Vicenzi, Marco, D'Ascenzo, Fabrizio, De Ferrari, Gaetano Maria, Monticone, Silvia, Secco, Gioel G., Tavazzi, Guido, Forleo, Giovanni, Severino, Paolo, Fedele, Francesco, De Rosa, Francesco, McCullough, Peter A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744009/ https://www.ncbi.nlm.nih.gov/pubmed/35027137 http://dx.doi.org/10.1016/j.amjcard.2021.12.004

Ejemplares similares

Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome
por: Palazzuoli, Alberto, et al.
Publicado: (2020)

Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection
por: Ruocco, Gaetano, et al.
Publicado: (2020)

Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study
por: Palazzuoli, Alberto, et al.
Publicado: (2020)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties
por: Schiavone, Marco, et al.
Publicado: (2020)

Loop Diuretic Administration in Patients with Acute Heart Failure and Reduced Systolic Function: Effects of Different Intravenous Diuretic Doses and Diuretic Response Measurements
por: Ruocco, Gaetano, et al.
Publicado: (2019)

Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
por: Ansary, Tuba M., et al.
Publicado: (2019)

Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure
por: Amatruda, Jonathan G., et al.
Publicado: (2022)

Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial
por: Palazzuoli, Alberto, et al.
Publicado: (2014)

The Diuretic Effects of Coconut Water by Suppressing Aquaporin and Renin–Angiotensin–Aldosterone System in Saline-Loaded Rats
por: Wei, Jing, et al.
Publicado: (2022)

Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19)
por: Zhang, Jun, et al.
Publicado: (2021)

Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease
por: Garlo, Katherine G., et al.
Publicado: (2019)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

The use of diuretics in heart failure with congestion: we can't judge a book by its cover
por: Palazzuoli, Alberto, et al.
Publicado: (2019)

Brain renin angiotensin in disease
por: Phillips, M. Ian, et al.
Publicado: (2008)

Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR‐AHF
por: Palazzuoli, Alberto, et al.
Publicado: (2017)

Inpatient hospitalisation and mortality rate trends from 2004 to 2014 in the USA: a propensity score-matched case–control study of hyperkalaemia
por: Tecson, Kristen Michelle, et al.
Publicado: (2022)

Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak
por: Severino, Paolo, et al.
Publicado: (2020)

HEART FAILURE HOSPITALIZATION RATE REDUCTION DURING COVID-19 PANDEMIC
por: D’Amato, Andrea, et al.
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Risk Factors and Cellular Differences in Heart Failure: The Key Role of Sex Hormones
por: Delcuratolo, Elvira, et al.
Publicado: (2023)

Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis
por: Cheng, Yiming, et al.
Publicado: (2016)

Ventricular Fibrillation Storm in Coronavirus 2019
por: Elsaid, Ossama, et al.
Publicado: (2020)

COVID-19 in Europe: the Italian lesson
por: Saglietto, Andrea, et al.
Publicado: (2020)

Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine
por: Bocchino, Pier Paolo, et al.
Publicado: (2020)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
por: Feola, Mauro, et al.
Publicado: (2020)

The Renin-Angiotensin System Textbook
por: Cumming, Allan D
Publicado: (1994)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study
por: Harrison, Paul J, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
por: Palazzuoli, Alberto, et al.
Publicado: (2023)

Do Genetic Variants of the Renin-Angiotensin System Predict Blood Pressure Response to Renin-Angiotensin System–Blocking Drugs? A Systematic Review of Pharmacogenomics in the Renin-Angiotensin System
por: Konoshita, Tadashi
Publicado: (2011)

Renin-angiotensin system inhibition in COVID-19 patients
por: de Vries, A. A. F.
Publicado: (2020)

The renin–angiotensin system and diabetes: An update
por: Ribeiro-Oliveira, Antônio, et al.
Publicado: (2008)

ANGIOTENSIN AND RENIN IN RAT AND DOG BRAIN
por: Fischer-Ferraro, Catalina, et al.
Publicado: (1971)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3tj97dsbsukluf9m9idvmbmjmm